Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse

This publication has 14 references indexed in Scilit:

• Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C
  Annals of Internal Medicine, 2004
• Early Virologic Response to Treatment With Peginterferon Alfa–2B Plus Ribavirin in Patients With Chronic Hepatitis C
  Hepatology, 2003
• Highly sensitive hepatitis C virus RNA detection methods: molecular backgrounds and clinical significance
  Journal of Clinical Virology, 2002
• Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
  New England Journal of Medicine, 2002
• Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment
  American Journal of Gastroenterology, 2001
• Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
  Published by Elsevier ,2001
• Assessment, by Transcription-Mediated Amplification, of Virologic Response in Patients with Chronic Hepatitis C Virus Treated with Peginterferon α-2a
  Journal of Clinical Microbiology, 2001
• Performance characteristics of a transcription‐mediated nucleic acid amplification assay for qualitative detection of hepatitis C virus RNA
  Journal of Clinical Laboratory Analysis, 2001
• Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays
  Hepatology, 2000
• Hepatitis C: The clinical spectrum of disease
  Hepatology, 1997